Healthcare Professionals

Committed to helping you meet the evolving challenges and opportunities in patient care.

Healthcare Professionals

  • Providing innovative therapies and technologies to help you treat patients with life-threatening illnesses in the ICU.

  • From the pharmacy to the bedside, we help you maximize safety, streamline processes and build cost efficiency throughout the hospital.

  • Nutritional Care

    Acute and chronic nutritional care for your patients who are unable to get adequate nutrients orally or enterally.

  • Pioneering innovation in hemodialysis and peritoneal dialysis to help you achieve better outcomes for your patients.

  • Surgical Care

    Delivering innovative surgical products that help you operate with confidence, precision and speed.

  • Our portfolio of acute, nutritional, renal, hospital and surgical care products helps advance healthcare around the world.

Perspectives

For more than 85-years, we have worked at the intersection of saving and sustaining lives.

Perspectives

Our Story

Our more than 85-year heritage gives us distinct perspective on the needs of patients and caregivers. We lead today by putting those insights to work to deliver new, better healthcare solutions and access to care in the communities where we live and work.

Our Story
  • Our Governance

    We are proud of our strong commitment to maintaining the highest standards of corporate governance.

  • Fueling Collaborative Innovation

    Nurturing a culture of innovation is critical to delivering on our mission to save and sustain lives. We partner with the healthcare community to continually find more efficient, smarter ways to help solve the world's most pressing healthcare challenges.

  • We are committed to doing business the right way, ensuring that we champion our employees, our communities, our customers and patients, and our environment in everything we do.

  • Inclusion & Diversity

    We are committed to attracting, motivating and retaining an inclusive and diverse workforce.

  • Our History

    For more than 85 years, we’ve been focused on saving and sustaining lives and elevating patient care.

Patients

Helping you reach a healthy life, full of possibility.

Patients
  • Critical Care

    When every moment counts, our therapies help healthcare specialists provide life-sustaining treatment to you or your loved one.

  • From the pharmacy to the bedside, we support you and your healthcare providers with IV medications and infusion technologies designed with safety in mind.

  • When medical conditions prevent you from adequately feeding yourself, we provide life-saving clinical nutrition options to help you regain or maintain your health.

  • Chronic kidney disease (CKD) is an ongoing journey. While every journey is unique, Baxter is with you every step of the way, providing options to meet your lifestyle needs.

  • Surgical Care

    We partner with surgical teams around the world so they can operate with confidence, precision and speed for a successful outcome to your surgery.

Search Results

Baxter Named to 2019 Dow Jones Sustainability Indices

Baxter International Inc. (NYSE:BAX), a leading global medical products company, announced today it has again been named to the Dow Jones Sustainability Indices (DJSI)—the DJSI World and DJSI North America—designations Baxter has received annually since the indices were launched in 1999 and 2005, respectively.

Thumbnail image of Q-NRG

Baxter and COSMED Announce Partnership to Bring Next-Generation Indirect Calorimetry Device, Q-NRG+, to Support Clinical Nutrition Globally

Baxter International Inc. (NYSE: BAX), a global leader in clinical nutrition, and COSMED srl, a worldwide leader in the design of metabolic systems for clinical and human performance applications, today announced an agreement to commercialize Q-NRG+, a metabolic monitoring device utilizing indirect calorimetry technology. The agreement provides that Baxter will bring Q-NRG+ to 18 key countries around the world with potential for further expansion.

Image of Finomel triple-chamber bag

Baxter Adds Finomel With Fish Oil to Ready-To-Use Parenteral Nutrition Portfolio

Baxter International Inc. (NYSE:BAX), a global leader in clinical nutrition, announced today the European launch of Finomel, a ready-to-use triple-chamber bag for parenteral nutrition (PN). Finomel expands the company’s portfolio of leading premixed PN formulations and offers healthcare providers with additional options to meet adult patients’ diverse nutritional needs.

2019 Second Quarter Financial Results Thumbnail

Baxter Reports Second-Quarter 2019 Results

Baxter International Inc. (NYSE:BAX), a leading global medical products company, today reported earnings for the second quarter of 2019 and updated its full-year 2019 earnings outlook.

Corp Responsibility Report Thumbnail

Baxter Highlights Progress Toward Its 2020 Corporate Responsibility Goals and Efforts to Make a Meaningful Difference Around the World

Baxter International Inc. (NYSE:BAX), a leading global medical products company, announced today the release of its 2018 Corporate Responsibility Report, which showcases the company’s progress on key initiatives to drive more sustainable operations, enhance product quality, build healthy communities, foster a strong work environment and improve access to healthcare.

Baxter Declares Quarterly Dividend

Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced that its Board of Directors has declared a quarterly cash dividend of $0.19 per share of common stock. The dividend is payable on April 1, 2019, to shareholders of record as of March 1, 2019. The indicated annual dividend rate is $0.76 per share of common stock.

Baxter Highlights Renal Care Data About Patients’ Health-Related, Quality of Life Outcomes at the 56th ERA-EDTA Congress

Baxter International Inc. (NYSE:BAX), a global innovator in renal care, showcased 19 data presentations on therapy options at the 56th ERA-EDTA Congress, Budapest, Hungary, June 13-16. The presentations spanned the renal care continuum, from chronic kidney disease (CKD) management to peritoneal dialysis (PD) and hemodialysis (HD). This included five independent studies conducted on HDx (expanded hemodialysis) that further advance growing evidence for the therapy.

Hechingen, Germany Plant Image

Baxter Leads Hemodialysis Research Consortium for German Federal Ministry of Education and Research

Baxter International Inc. (NYSE:BAX), a global innovator in renal care, today announced receipt of a major research and development (R&D) grant from the German Federal Ministry of Education and Research (BMBF)’s “From Material to Innovation” program to lead a consortium investigating an anticoagulation-free hemodialysis (HD) option for end-stage renal disease (ESRD) patients.

Claria and Amia PD Systems

Baxter Launches Sharesource 2.0 Telehealth Platform to Support Greater Clinical Insights and Personalized Peritoneal Dialysis Care

Baxter International Inc. (NYSE:BAX), a global innovator in renal care, announced today the launch of the Sharesource 2.0 clinical portal to give healthcare providers greater insights to their patients' home peritoneal dialysis (PD) treatments, while offering improved clinic workflow.

Opearation Smile program aims to advance the availability of surgical care in India

The Baxter International Foundation Commits $2 Million+ to Operation Smile Care Centers in India

The Baxter International Foundation, the philanthropic arm of Baxter International Inc. (NYSE:BAX), announced today a $2.2 million grant to Operation Smile, one of the world’s largest volunteer-based surgical nonprofit organizations, to deliver free surgical and multidisciplinary care to underserved communities in India.